research Frontal Fibrosing Alopecia: Histopathological and Immunohistochemical Study of the Inflammatory Infiltrate and the Sebaceous Gland Receptors
Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.
Search
for
Sort by
Research
510-540 / 790 results
research Comorbid Conditions in Lichen Planopilaris: A Retrospective Data Analysis of 334 Patients
Lichen planopilaris patients often have other health conditions too.
research Tolerance and Efficacy of a New Emollient Barrier Cream in Pediatric and Adult Population with Mild to Moderate Atopic Dermatitis
The new cream is safe and effective for mild to moderate atopic dermatitis.
research Tolerance and Efficacy of a New Emollient Barrier Cream in Adults with Mild to Moderate Chronic Hand Dermatitis
research A Case of Altered Hair Texture After Resolution of Alopecia Areata
New hair after alopecia areata can be thinner and change color but usually keeps the same shape.
research The Effect of a Novel Zinc Pyrithione Hair Care System on Female Scalp Condition
The zinc pyrithione hair care system improves scalp hydration and reduces water loss.
research Follicular Red Dots in Areas with Anatomic Colocalization of Alopecia Areata and Vitiligo
Follicular red dots can appear where alopecia areata and vitiligo overlap.
research Low-Dose Oral Minoxidil Improves Hair Density in Traction Alopecia
Low-dose oral minoxidil helps increase hair density in traction alopecia.
research Untargeted Metabolomics and Steroid Signatures in Urine of Male Pattern Baldness Patients After Finasteride Treatment for a Year
Finasteride treatment changes hormone levels in male pattern baldness patients.
research The Use of Cyclosporine in Dermatology: Part I
Cyclosporine is effective for skin conditions but has declined in use due to toxicity concerns.
research Defining Pseudofolliculitis Barbae in 2001: A Review of the Literature and Current Trends
Pseudofolliculitis barbae is a chronic skin condition affecting mainly African American and Hispanic individuals, caused by shaving tightly curled hair, and managed by prevention and treatment but not curable.
research Health-Related Quality of Life Among Patients With Alopecia Areata: A Systematic Review
People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.
research Topical Tretinoin for Hair Growth Promotion
Tretinoin may help hair growth and works better when combined with minoxidil.
research Single Hair Grafting for the Treatment of Vitiligo
Single hair grafting is effective for treating small, localized patches of vitiligo.
research Topical Photochemotherapy for Alopecia Areata
Topical PUVA can cause temporary hair regrowth in some alopecia areata patients but doesn't change the long-term outcome.
research All Hairstyles Are Not Created Equal: What the Dermatologist Needs to Know About Black Hairstyling Practices and the Risk of Traction Alopecia
Certain black hairstyling practices increase the risk of traction alopecia, requiring better management and education.
research Phase I/II Randomized Bilateral Half-Head Comparison of Topical Bexarotene 1% Gel for Alopecia Areata
Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.
research Medical and Aesthetic Procedural Dermatology Recommendations for Transgender Patients Undergoing Transition
Dermatologists are important in helping transgender people with skin issues and physical changes during their transition.
research Gender Reassignment: Modifying Facial and Neck Structures for Gender Dysphoria
The conclusion is that certain surgeries can help people with gender dysphoria look more like their true gender and feel better.
research Recent Advances in the Treatment of Polycystic Ovary Syndrome
Treatments for Polycystic Ovary Syndrome (PCOS) focus on reducing symptoms, restoring regular periods, and helping with pregnancy. Common treatments include hormone suppressors, fertility drugs, and insulin-sensitising agents.
research Spironolactone Use Does Not Increase the Risk of Female Breast Cancer Recurrence: A Retrospective Analysis
Taking spironolactone doesn't increase the chance of breast cancer coming back.
research Evaluation of Platelet-Rich Plasma on Hair Regrowth and Lesional T-Cell Cytokine Expression in Alopecia Areata: A Randomized Observer-Blinded, Placebo-Controlled, Split-Head Pilot Study
Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.
research Hair Cross-Sectioning in Uncombable Hair Syndrome: An Easy Tool for Complex Diagnosis
The document suggests finding a simpler, cheaper way to diagnose Uncombable Hair Syndrome.
research Thinking About Sex in Education
The conclusion is that sex education should encourage critical thinking and be open to new scientific perspectives.
research Colored Dots on Trichoscopy—Beware of Artifacts
Some hair products can create false signs on scalp examinations, leading to wrong diagnoses.
research Folliculotropic Mycosis Fungoides Following Renal Transplantation
A man developed a skin cancer called folliculotropic mycosis fungoides after a kidney transplant.
research The Inflammatory Component of Androgenetic Alopecia
Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.
research Scalp-Sparing Total Skin Electron Therapy in Mycosis Fungoides: Case Report Highlighting Technique and Outcome
Total skin electron therapy is an effective treatment for mycosis fungoides, balancing effectiveness and side effects.
research Hutchinson-Gilford Progeria Syndrome: Report of 2 Cases and a Novel LMNA Mutation in China
A new genetic mutation linked to Hutchinson-Gilford progeria syndrome was found in China.
research Human Dermal Safety Studies with Eflornithine HCl 13.9% Cream (Vaniqa), a Novel Treatment for Excessive Facial Hair
Eflornithine HCl 13.9% cream (Vaniqa™) was evaluated for dermal safety in four studies involving 230 subjects. The cream was found to cause erythema with oedema in 38.9% of subjects, compared to 4.8% with the vehicle cream. In a cumulative irritation study with 30 subjects, the cream had a mean irritation score of 1.33, which was lower than the positive control but higher than the vehicle. Phototoxicity and photocontact allergy studies showed no serious reactions, with mild erythema subsiding within 24 hours. No serious adverse events were reported, and the cream did not exhibit contact sensitizing, photocontact allergic, or phototoxic properties. It was concluded that eflornithine HCl 13.9% cream had a favorable dermal safety profile suitable for routine topical application.